pharmaceutical approvals India – The Milli Chronicle

Monday, February 2, 2026

Latest:

Factual Version of a Story

Asia Latest News

NewsDesk Milli Chronicle January 24, 2026 affordable weight loss drugs, Alkem semaglutide approval, diabetes semaglutide India, generic GLP-1 drugs, generic Ozempic India, generic Wegovy India, healthcare affordability India, Indian drugmakers obesity race, Indian pharma industry growth, Indian pharma semaglutide, obesity drugs India, obesity medicine competition, obesity treatment market, pharma market India 2026, pharmaceutical approvals India, semaglutide generic approval, Sun Pharma obesity drug, weight loss drug demand, weight loss medicine India, Zydus weight loss drug

Indian Drugmakers Enter Obesity Treatment Market With Generic Wegovy Approval

Mumbai – India’s pharmaceutical industry is set to intensify competition in the booming obesity and diabetes drug market after regulators

Asia Latest News

NewsDesk Milli Chronicle January 21, 2026January 21, 2026 diabetes drug India, diabetes treatment India, Dr Reddy’s Laboratories news, Dr Reddy’s Ozempic generic, generic drug launch, generic Ozempic India, GLP-1 drugs India, healthcare India market, Indian pharma industry, Novo Nordisk patent expiry, obesity drug market, Ozempic alternative India, pharmaceutical approvals India, Reuters India pharma, Semaglutide India launch, Semaglutide pens, weight loss drug India

Dr Reddy’s gets regulatory nod to sell generic Ozempic in India, targets 12 million pens in first year

Hyderabad – Indian pharmaceutical major Dr Reddy’s Laboratories has received regulatory approval to manufacture and sell a generic version of